Robert A. Hegele MD, FRCPCJacob J. Wolfe Distinguished Medical Research Chair, Martha Blackburn Chair in Cardiovascular Research, Distinguished University Professor of Medicine and Biochemistry, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada
Robert Hegele is an endocrinologist and lipidologist who cares for > 2500 patients at the lipid clinic at University Hospital, London, Ontario, Canada. He holds the Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Chair in Human Genetics and the Blackburn Chair in Cardiovascular Research at the Schulich School of Medicine and Dentistry, Western University. His lab discovered the molecular genetic basis of >20 human diseases, including hepatic lipase deficiency and two forms of familial partial lipodystrophy. He holds a Foundation grant from Canadian Institutes of Health Research and has received uninterrupted operating support since 1990. He was first in North America to use 5 medications that are now routinely prescribed to treat high cholesterol or diabetes. He has published 760 papers, which have been cited >30,000 times in the medical literature, and is in the Clarivate top 1% of highly cited scientists. The website expertscape.com in 2019 ranked him #1 globally in the area of “hypertriglyceridemia” and #1 for “disorders of lipid metabolism”. In 2019 he received the American Heart Association George Lyman Duff Memorial Award in Atherosclerosis Research. He has co-authored many clinical practice guidelines for cholesterol, blood pressure and diabetes. He has trained numerous physicians, medical students and graduate students.
Dr. Hegele receives consulting fees from Acasti, Akcea/Ionis, Amgen, HLS Therapeutics, Regeneron and Sanofi.